Author: CardioNewsUK

By Dr Aswin Babu Tarakji et al. (2022) recently published post hoc analysis of 2,803 control patients from the WRAP-IT trial who underwent secondary device…

View More Machine learning predicts factors associated with device infection during secondary procedures

By Dr Jonathan Shurlock The use of anticoagulation to reduce the risk of stroke in patients with AF is widespread, often protocol driven, and guided…

View More Atrial fibrillation and silent infarcts, is anticoagulation enough?

By Dr Timothy Swinn The Medicines & Healthcare products Regulation Agency (MHRA) in the UK uses the voluntary “Yellow Card” system for reporting suspected adverse…

View More Post-COVID vaccine myocarditis: UK reporting rates and recent statistics

By Dr Jonathan Shurlock Multiple population level studies have demonstrated the association between objective or perceived social isolation and cardiovascular risk. Golaszewski et al. have…

View More Consistent evidence for the role of social isolation in cardiovascular risk

By Dr Jonathan Shurlock Patients with aortic stenosis (AS) have received increasing attention with recent work raising concerns regarding the assumption of being low risk…

View More Can ‘low-risk’ patients with aortic stenosis be stratified?

By Dr Megha Agarwal Multi-disciplinary meetings form an important part of the clinical pathway for complex heart failure patients. The above titled document aims to…

View More A summary of… Heart failure multidisciplinary meetings: joint British Society consensus guidelines for structure and function

By Dr Oliver Jones Key points: In FAME 3, PCI failed to meet noninferiority versus CABG for composite MACE in three-vessel CAD patients without severe…

View More FAME 3 published and guideline updates: PCI vs CABG in multivessel disease debate continues.

By Dr Megha Agarwal A new study1 has been published in JAMA evaluating whether there is a difference in risk of major ischemic or haemorrhagic…

View More At loggerheads: rivaroxaban vs apixaban

By Dr Aswin Babu PRAGUE-17 was a multi-centre, prospective, randomised, non-inferiority trial assessing the efficacy of left atrial appendage closure (LAAC) when compared to direct…

View More A win for left atrial appendage occlusion devices